NCT00051220

Brief Summary

This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Oct 2001

Longer than P75 for phase_1

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 7, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 8, 2003

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2006

Completed
Last Updated

June 7, 2013

Status Verified

June 1, 2013

Enrollment Period

4.9 years

First QC Date

January 7, 2003

Last Update Submit

June 6, 2013

Conditions

Interventions

Eligibility Criteria

Age7 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Primary diagnosis of specific phobia disorder

You may not qualify if:

  • Mental retardation
  • Developmental disabilities
  • Suicide threat

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

VA Polytech. Institute and State University

Blacksburg, Virginia, United States

Location

University of Stockholm

Stockholm, Sweden

Location

MeSH Terms

Conditions

Phobic DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 7, 2003

First Posted

January 8, 2003

Study Start

October 1, 2001

Primary Completion

September 1, 2006

Study Completion

September 1, 2006

Last Updated

June 7, 2013

Record last verified: 2013-06

Locations